MENU
SCTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Scribe Therapeutics (SCTX) Earnings Date & Reports

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines... Show more

A.I. Advisor
published Earnings

SCTX is expected to report earnings to fall 89.06% to -41 cents per share on December 02

Scribe Therapeutics SCTX Stock Earnings Reports
Q3'26
Est.
$-0.42
Q2'26
Beat
by $2.36
The last earnings report on September 02 showed earnings per share of -383 cents, beating the estimate of -619 cents. With 103.84K shares outstanding, the current market capitalization sits at 365.38M.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1150 Marina Village Parkway
Phone
+1 510 626-8587
Employees
89
Web
https://www.scribetx.com